Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D McCormick

Showing results (391-400 of 405) with videos related to

Pageof 41
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
Open Forum Infectious Diseases|June 2, 2023
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody TherapyJana L Jacobs, Ghady Haidar, Asma Naqvi, et al.
Pediatric Cardiology|March 26, 2026
Transforming Pediatric Cardiology Fellowship Education: Multi-center Outcomes of the MACH-3 Virtual Reality Program for HLHSAmanda D McCormick, Benjamin W Pritz, Sunkyung Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesJoseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Journal of the International AIDS Society|August 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South AfricaUrvi M Parikh, Lauren D Kudrick, Lisa Levy, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of AsthmaXianhai Huang, Jason Brubaker, Wei Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonistsMichael Berlin, Pauline C Ting, Wayne D Vaccaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised PatientsGhady Haidar, Jana L Jacobs, Kailey Hughes Kramer, et al.
The Review of Scientific Instruments|August 3, 2015
Mega-electron-volt ultrafast electron diffraction at SLAC National Accelerator LaboratoryS P Weathersby, G Brown, M Centurion, et al.
Iscience|July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domainsChuan Chen, James W Saville, Michelle M Marti, et al.
Pageof 41

Showing results (391-400 of 405) with videos related to

Sort By:
Pageof 41
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
Open Forum Infectious Diseases|June 2, 2023
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody TherapyJana L Jacobs, Ghady Haidar, Asma Naqvi, et al.
Pediatric Cardiology|March 26, 2026
Transforming Pediatric Cardiology Fellowship Education: Multi-center Outcomes of the MACH-3 Virtual Reality Program for HLHSAmanda D McCormick, Benjamin W Pritz, Sunkyung Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesJoseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Journal of the International AIDS Society|August 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South AfricaUrvi M Parikh, Lauren D Kudrick, Lisa Levy, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of AsthmaXianhai Huang, Jason Brubaker, Wei Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonistsMichael Berlin, Pauline C Ting, Wayne D Vaccaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised PatientsGhady Haidar, Jana L Jacobs, Kailey Hughes Kramer, et al.
The Review of Scientific Instruments|August 3, 2015
Mega-electron-volt ultrafast electron diffraction at SLAC National Accelerator LaboratoryS P Weathersby, G Brown, M Centurion, et al.
Iscience|July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domainsChuan Chen, James W Saville, Michelle M Marti, et al.
Pageof 41